Advertisement

Removal of Bilirubin from Blood by Affinity-Competition Chromatography over Albumin-Agarose Gel

  • Paul D. Berk
  • Paul H. Plotz
  • Bruce F. Scharschmidt

Abstract

Largely as the result of advances in artificial kidney design, there have been dramatic improvements in the well-being and survival of patients with acute and chronic renal disease during the past several decades (Klebba et al., 1974; Maher et al.,1974). In contrast, despite the introduction of numerous new therapeutic approaches, there has been little improvement over the same period in the survival of patients with acute fulminant hepatic failure (Benhamou et al.,1972). As a result of the continuing bleak prognosis for this condition, hepatologists are increasingly considering the feasibility of some sort of artificial device to perform temporarily some of the excretory functions of an acutely failing liver (Berk et al., 1976a, 1976b). Both laboratory and clinical interest has focused on extracorporeal perfusion through columns of sorbents such as charcoal or synthetic resins, which remove a wide range of molecular species from blood with variable efficiency and relatively low specificity. In the setting of fulminant hepatic failure, the low specificity of such systems is, in a sense, desirable since the particular biochemical abnormalities requiring correction are not precisely known (Breen and Schenker, 1972; Schenker et al., 1974; Fischer, 1974; Zieve, 1975). The most extensive clinical experience has been with charcoal hemoperfusion (Chang, 1972; Chang and Migchelson, 1973; Gazzard et al.,1974a; Williams, 1976), but in view of the lack of suitable randomized controls, the effectiveness of this procedure remains unclear (Berk et al., 1976a).

Keywords

Human Serum Albumin Fulminant Hepatic Failure Activate Charcoal Lithocholic Acid Hepatic Coma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andrade, J. D., Kunitomo, K., Van Wagenen, R., Kastigir, B., Gough, D., and Kolff, J., 1971, Coated adsorbents for direct blood perfusion: hema/activated carbon, Trans. Amer. Soc. Artificial Internal Organs 17: 222–238.Google Scholar
  2. Arias, I. M., Gartner, L. M., Cohen, M., Ben-Ezzer, J., and Levi, A. J., 1969, Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: clinical, biochemical, pharmacologic and genetic evidence for heterogeneity, Amer. J. Med. 47: 395–409.CrossRefGoogle Scholar
  3. Axen, R., Porath, J., and Ernback, S., 1967, Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides, Nature 214: 1302–1304.CrossRefGoogle Scholar
  4. Barakat, T., and MacPhee, I. W., 1970, Experiments with an extracorporeal carbon column as a simplified artificial kidney, Brit. J. Surg. 57: 580–583.CrossRefGoogle Scholar
  5. Benhamou, J.-P., Rueff, B., and Sicot, C., 1972, Severe hepatic failure: a critical study of current therapy, in: Liver and Drugs ( F. Orlandi and A. M. Jezequel, eds.), Academic Press, Inc., New York.Google Scholar
  6. Berk, P. D., Howe, R. B., Bloomer, J. R., and Berlin, N. I., 1969, Studies of bilirubin kinetics in normal adults, J. Clin. Invest. 48: 2176–2190.CrossRefGoogle Scholar
  7. Berk, P. D., Bloomer, J. R., Howe, R. D., and Berlin, N. I., 1970, Constitutional hepatic dysfunction (Gilbert’s syndrome): a new definition based on kinetic studies with unconjugated radio-bilirubin, Amer. J. Med. 49: 296–305.CrossRefGoogle Scholar
  8. Berk, P. D., Berlin, N. I., and Howe, R. B., 1974, Disorders of bilirubin metabolism, in: Duncan’s Diseases of Metabolism (P. K. Bondy and L. Rosenberg, eds.), 7th ed., W. B. Saunders Company, Philadelphia.Google Scholar
  9. Berk, P. D., Martin, J. F., Blaschke, T. F., Scharschmidt, B. F., and Plotz, P. H., 1975, Unconjugated hyperbilirubinemia: physiologic evaluation and experimental approaches to therapy, Ann. Internal Med. 82: 552–570.Google Scholar
  10. Berk, P. D., Scharschmidt, B. F., Martin, J. F., and Plotz, P. H., 1976a, Artificial support systems for liver failure, Kidney Inst. 10 (7): S233.Google Scholar
  11. Berk, P. D., Martin, J. F., Scharschmidt, B. F., and Plotz, P. H., 1976b, Current status of artificial hepatic support systems, in: Progress in Liver Disease (H. Popper and F. Schaffner, eds.), 5th ed., Grune and Stratton, Inc., New York.Google Scholar
  12. Blaschke, T. F., Berk, P. D., Scharschmidt, B. F., Guyther, J. R., Vergalla, J., and Waggoner, J. G., 1974, Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age 18, Pediat. Res. 8: 573–590.CrossRefGoogle Scholar
  13. Bloomer, J. R., Berk, P. D., Howe, R. B., and Berlin, N. I., 1971, Bilirubin metabolism in congenital nonhemolytic jaundice, Pediat. Res. 5: 256–274.CrossRefGoogle Scholar
  14. Blumenschein, S. D., Kallan, R. J., Storey, B., Natzschka, C., Odell, G. B., and Childs, B., 1968, Familial nonhemolytic jaundice with late onset of neurologic damage, Pediatrics 42: 786–792.Google Scholar
  15. Breen, K. J., and Schenker, S., 1972, Hepatic coma: present concepts of pathogenesis and therapy, in: Progress in Liver Disease (H. Popper and F. Schaffner, eds.), Vol. 4, Grune and Stratton, Inc., New York.Google Scholar
  16. Chang, T. M. S., 1972, Hemoperfusion over microencapsulated absorbent in a patient with hepatic coma, Lancet 2: 1371–1372.CrossRefGoogle Scholar
  17. Chang, T. M. S., and Migchelson, M., 1973, Characterization of possible “toxic” metabolites in uremia and hepatic coma based on the clearance spectrum for larger molecules by the ACAC microcapsule artificial kidney, Trans. Amer. Soc. Artificial Internal Organs 17: 246–252.Google Scholar
  18. Chang, T. M. S., Chisito, E., Barre, P., Cole, C., and Hawish, M., 1975, Clinical performance characteristics of a new combined system for simultaneous hemoperfusion-hemodialysis-ultrafiltration in series, Tram. Amer. Soc. Artificial Internal Organs 21: 502–509.Google Scholar
  19. Cohn, H. E., Weiss, A. J., Clark, J. E., and Nealon, T. F., 1960, An ion exchange resin artificial kidney, Surg. Forum 11: 15–17.Google Scholar
  20. Cuatrecasas, P., and Anfinsen, C. B., 1971, Affinity chromatography, Ann. Rev. Biochem. 40:259–278. Dunea, G., and Kolff, W. J., 1965, Clinical experiences with the Yatzidis charcoal kidney, Trans. Amer. Soc. Artificial Internal Organs 11: 178–182.Google Scholar
  21. Fischer, J. E., 1974, Hepatic coma in cirrhosis, portal hypertension, and following portocaval shunt, Arch. Surg. 108: 325–336.CrossRefGoogle Scholar
  22. Gazzard, B. G., Weston, M. J., Murray-Lyon, I. M., Flax, H., Record, C. O., Portman, B., Langley, P. G., Dunlop, E. H., Mellon, P. J., Ward, M. B., and Williams, R., 1974a, Charcoal hemoperfusion in the treatment of fulminant hepatic failure, Lancet 1: 1301–1307.CrossRefGoogle Scholar
  23. Gazzard, B. G., Buxton, B. H., Winch, J., Machado, A. L., Flax, H., and Williams, R., 1974b, Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure, Gut 15: 482–486.CrossRefGoogle Scholar
  24. Grollman, A. P., and Odell, G. B., 1962, Removal of bilirubin by albumin binding during intermittant peritoneal dialysis, New Engl. J. Med. 267: 279–282.CrossRefGoogle Scholar
  25. Inman, J. K., and Dintzis, H. M., 1969, The derivatization of cross-linked polyacrylamide beads: controlled introduction of functional groups for the preparation of special purpose, biochemical adsorbents, Biochemistry 8: 4074–4082.CrossRefGoogle Scholar
  26. Jacobsen, J., 1969, Binding of bilirubin to human serum albumin—determination of the dissociation constants, FEBS Letters 5: 112–114.CrossRefGoogle Scholar
  27. Juggi, J. S., 1971, In vivo studies with a cation exchange resin mixture in the removal of excessive ammonium from the extracorporeal circulation system, Australian New Zealand J. Surg. 41: 194–200.Google Scholar
  28. Juggi, J. S., 1973, Extracorporeal cation exchange circuits in the treatment of hyperammonemia of liver failure, Med. J. Australia 1: 926–930.Google Scholar
  29. Khorona, H. G., 1955, The use of dicyclohexylcarbodiimide in the synthesis of peptides, Chem. Ind. (London) August: 1087–1088.Google Scholar
  30. Klebba, A. J., Maurer, J. D., and Glass, E. J., 1974, Mortality trends for leading causes of death: United States, 1950–69 (National Center for Health Statistics: data from the National Vital Statistics System, ser. 20, no. 16), U.S. Department of Health, Education and Welfare Publication No. (HRA) 741853, Government Printing Office, Washington.Google Scholar
  31. Maher, J. F., Nolph, K. D., and Bryan, C. W., 1974, Prognosis of advanced chronic renal failure, Ann. Internal Med. 81: 43–47.Google Scholar
  32. Pallotta, A. J., and Koppanyi, T., 1960, The use of ion exchange resins in the treatment of phenobarbital intoxication in dogs, J. Pharmacol. Exptl. Therapy 128: 318–327.Google Scholar
  33. Plotz, P. H., Berk, P. D., Scharschmidt, B. F., Gordon, J. K., and Vergalla, J., 1974, Removing substances from blood by affinity chromatography: 1. Removal of bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads, J. Clin. Invest. 53: 778–785.CrossRefGoogle Scholar
  34. Porath, J., and Sundberg, L., 1972, High capacity chemisorbents for protein immobilization, Nature New Biol. 238: 261–262.Google Scholar
  35. Rosenthal, I. M., Zimmerman, H. J., and Hardy, M., 1956, Congenital nonhemolytic jaundice with disease of the central nervous system, Pediatrics 18: 378–386.Google Scholar
  36. Rudman, D., and Kendall, F. E., 1957, Bile acid content of human serum: II. The binding of cholanic acids by human plasma proteins, J. Clin. Invest. 36: 538–542.CrossRefGoogle Scholar
  37. Scharschmidt, B. F., and Berk, P. D., 1973, A simple device to facilitate rapid blood sampling in small animals, Proc. Soc. Exptl. Biol. Med. 143: 364–366.Google Scholar
  38. Scharschmidt, B. F., Berk, P. D., and Waggoner, J. G., 1973, Bilirubin kinetics in the normal rat, Clin. Res. 21: 523.Google Scholar
  39. Scharschmidt. B. F., Plotz, P. H., Berk. P. D., Waggoner, J. G., and Vergalla, J., 1974, Removing substances from blood by affinity chromatography: II. Removing bilirubin from the blood of jaundiced rats by hemoperfusion over albumin-conjugated agarose beads. J. Clin. Invest. 53: 786–795.CrossRefGoogle Scholar
  40. Scharschmidt, B. F., Martin, J. F., Shapiro, L. J., Plotz, P. H., and Berk, P. D., 1975a, Hemoperfusion through albumin-agarose gel (AAG) for the treatment of neonatal jaundice in premature Rhesus monkeys, Gastroenterology 69: 864.Google Scholar
  41. Scharschmidt, B. F., Martin, J. F., Shapiro, L. J., Plotz, P. H., and Berk, P. D., 1975b, Use of calcium chelating agents and prostaglandin E, (PGE,) to eliminate platelet losses during hemoperfusion through various adsorbents, Gastroenterology 69: 864.Google Scholar
  42. Schenker, S., Breen, K. J., and Hoyumpa, A. M., Jr., 1974, Hepatic encephalopathy: current status, Gastroenterology 66: 121–154.Google Scholar
  43. Sheehan, J. C., and Hess, G. P., 1955, A new method for forming peptide bonds, J. Amer. Chem. Soc. 77: 1067–1068.CrossRefGoogle Scholar
  44. Smith, T. W., 1972, Contribution of quantitative assay technics to the understanding of the clinical pharmacology of digitalis, Circulation 46: 188–199.Google Scholar
  45. Williams, R., 1976, Hepatic failure and the development of an artificial liver support system, in: Progress in Liver Disease (H. Popper and F. Schaffner, eds.), Vol. 5, Grune and Stratton, Inc., New York.Google Scholar
  46. Willson, R. A., Webster, K. H., Hoffman, A. F., and Summerskill, W. H. J., 1972, Towards an artificial liver: in vitro removal of unbound and protein bound plasma compounds related to hepatic failure, Gastroenterology 62: 1191–1199.Google Scholar
  47. Willson, R. A., Hofmann, A. F., and Kuster, G. G. R., 1974, Toward an artificial liver: II. Removal of cholephilic anions from dogs with biliary obstruction by hemoperfusion through charcoal and uncharged resins, Gastroenterology 66: 95–107.Google Scholar
  48. Wolkoff, A. W., Scharschmidt, B. F., Plotz, P. H., and Berk, P. D., 1976, Purification of conjugated bilirubin: a new approach utilizing albumin-agarose gel affinity chromatography, Proc. Soc. Extl. Biol. Med. 152: 20.Google Scholar
  49. Zieve, L., 1975, Metabolic abnormalities in hepatic coma and potential toxins to be removed, in: Artificial Hepatic Support ( R. Williams and I. M. Murray-Lyon, eds.), pp. 11–26, Sir Isaac Pitman and Sons I.td., London.Google Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Paul D. Berk
    • 1
  • Paul H. Plotz
    • 2
  • Bruce F. Scharschmidt
    • 1
  1. 1.Section on Diseases of the Liver, Digestive Disease BranchNational Institutes of HealthBethesdaUSA
  2. 2.Arthritis and Rheumatism BranchNational Institutes of HealthBethesdaUSA

Personalised recommendations